🇺🇸 FDA
Pipeline program

Talampanel

ALS-TAL-201-OL

Phase 2 small_molecule terminated

Quick answer

Talampanel for Amyotrophic Lateral Sclerosis is a Phase 2 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Amyotrophic Lateral Sclerosis
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials